GB0307998D0 - Compounds - Google Patents

Compounds

Info

Publication number
GB0307998D0
GB0307998D0 GB0307998A GB0307998A GB0307998D0 GB 0307998 D0 GB0307998 D0 GB 0307998D0 GB 0307998 A GB0307998 A GB 0307998A GB 0307998 A GB0307998 A GB 0307998A GB 0307998 D0 GB0307998 D0 GB 0307998D0
Authority
GB
United Kingdom
Prior art keywords
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0307998A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to GBGB0230045.7A priority Critical patent/GB0230045D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GB0307998A priority patent/GB0307998D0/en
Publication of GB0307998D0 publication Critical patent/GB0307998D0/en
Priority to JP2005502565A priority patent/JP4872068B2/en
Priority to AU2003293999A priority patent/AU2003293999B2/en
Priority to PL392790A priority patent/PL392790A1/en
Priority to SI200331834T priority patent/SI1581532T1/en
Priority to BR0317645-2A priority patent/BR0317645A/en
Priority to KR1020057011852A priority patent/KR101088848B1/en
Priority to US10/540,371 priority patent/US7528148B2/en
Priority to DE60332396T priority patent/DE60332396D1/en
Priority to NZ540923A priority patent/NZ540923A/en
Priority to DK03789413.6T priority patent/DK1581532T3/en
Priority to PT03789413T priority patent/PT1581532E/en
Priority to NZ570085A priority patent/NZ570085A/en
Priority to MXPA05006923A priority patent/MXPA05006923A/en
Priority to ARP030104755A priority patent/AR043683A1/en
Priority to CA2511340A priority patent/CA2511340C/en
Priority to ES03789413T priority patent/ES2345385T3/en
Priority to AT03789413T priority patent/ATE466012T1/en
Priority to PCT/EP2003/014867 priority patent/WO2004056823A1/en
Priority to PL377880A priority patent/PL377880A1/en
Priority to CN2003801098350A priority patent/CN1751042B/en
Priority to EP03789413A priority patent/EP1581532B1/en
Priority to TW098134389A priority patent/TW201004956A/en
Priority to TW092136553A priority patent/TWI354671B/en
Priority to IL169335A priority patent/IL169335A0/en
Priority to CO05061771A priority patent/CO5690642A2/en
Priority to IS7913A priority patent/IS2795B/en
Priority to MA28404A priority patent/MA27615A1/en
Priority to NO20053600A priority patent/NO332354B1/en
Priority to HK06104030.8A priority patent/HK1084384A1/en
Priority to ZA200605901A priority patent/ZA200605901B/en
Priority to AU2010202035A priority patent/AU2010202035B9/en
Priority to CY20101100688T priority patent/CY1110676T1/en
Ceased legal-status Critical Current

Links

GB0307998A 2002-12-23 2003-04-07 Compounds Ceased GB0307998D0 (en)

Priority Applications (34)

Application Number Priority Date Filing Date Title
GBGB0230045.7A GB0230045D0 (en) 2002-12-23 2002-12-23 Compounds
GB0307998A GB0307998D0 (en) 2003-04-07 2003-04-07 Compounds
EP03789413A EP1581532B1 (en) 2002-12-23 2003-12-19 Pyrazolo¬3,4-b pyridine compounds, and their use as phosphodiesterase inhibitors
CA2511340A CA2511340C (en) 2002-12-23 2003-12-19 Pyrazolo[3,4-b]pyridine compounds, and their use as phosphodiesterase inhibitors
PCT/EP2003/014867 WO2004056823A1 (en) 2002-12-23 2003-12-19 PYRAZOLO[3,4-b]PYRIDINE COMPOUNDS, AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS
PL392790A PL392790A1 (en) 2002-12-23 2003-12-19 Pyrazole [3, 4-b] pyridine compounds and the use thereof as phosphodiesterase inhibitors
SI200331834T SI1581532T1 (en) 2002-12-23 2003-12-19 Pyrazolo 3,4-b pyridine compounds, and their use as phosphodiesterase inhibitors
BR0317645-2A BR0317645A (en) 2002-12-23 2003-12-19 Compound or a salt thereof, pharmaceutical composition, use of a compound, and method of treating and / or prophylaxis of an inflammatory and / or allergic disease or cognitive impairment in a mammal
KR1020057011852A KR101088848B1 (en) 2002-12-23 2003-12-19 PYRAZOLO[3,4-b] PYRIDINE COMPOUNDS, AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS
US10/540,371 US7528148B2 (en) 2002-12-23 2003-12-19 Pyrazolo[3,4-B]pyridine compounds, and their use as phosphodiesterase inhibitors
DE60332396T DE60332396D1 (en) 2002-12-23 2003-12-19 PYRAZOLOi3,4-B PYRIDINE COMPOUNDS AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS
NZ540923A NZ540923A (en) 2002-12-23 2003-12-19 Pyrazolo[3,4-b]pyridine compounds, and their use as phosphodiesterase inhibitors
DK03789413.6T DK1581532T3 (en) 2002-12-23 2003-12-19 Pyrazolo-3,4-B pyridine compounds and their use as phosphodiesterase inhibitors
PT03789413T PT1581532E (en) 2002-12-23 2003-12-19 Pyrazolo¼3,4-b pyridine compounds, and their use as phosphodiesterase inhibitors
NZ570085A NZ570085A (en) 2002-12-23 2003-12-19 Pyrazolo[3,4-b]pyridine compounds, and their use as phosphodiesterase inhibitors
MXPA05006923A MXPA05006923A (en) 2002-12-23 2003-12-19 PYRAZOLO[3,4-b]PYRIDINE COMPOUNDS, AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS.
ARP030104755A AR043683A1 (en) 2002-12-23 2003-12-19 COMPOUNDS DERIVED FROM PIRAZOLO [3,4- B] PIRIDINA, ITS USE AS PHOSPHODESTERASE INHIBITORS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
JP2005502565A JP4872068B2 (en) 2002-12-23 2003-12-19 Pyrazolo [3,4-b] pyridine compounds and their use as phosphodiesterase inhibitors
ES03789413T ES2345385T3 (en) 2002-12-23 2003-12-19 PIRAZOLO COMPOUNDS (3,4-B) PIRIDINE, AND ITS USE AS PHOSPHODESTERASE INHIBITORS.
AT03789413T ATE466012T1 (en) 2002-12-23 2003-12-19 PYRAZOLO 3,4-B PYRIDINE COMPOUNDS AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS
AU2003293999A AU2003293999B2 (en) 2002-12-23 2003-12-19 Pyrazolo[3,4-b]pyridine compounds, and their use as phosphodiesterase inhibitors
PL377880A PL377880A1 (en) 2002-12-23 2003-12-19 Pyrazolo[3,4-b]pyridine compounds, and their use as phosphodiesterase inhibitors
CN2003801098350A CN1751042B (en) 2002-12-23 2003-12-19 Pyrazolo[3,4-b]pyridine compounds, and their use as phosphodiesterase inhibitors
TW092136553A TWI354671B (en) 2002-12-23 2003-12-23 Pyrazolo[3,4-b]pyridine compounds, and their use a
TW098134389A TW201004956A (en) 2002-12-23 2003-12-23 Pyrazolo[3,4-b]pyridine compounds, and their use as phosphodiesterase inhibitors
IL169335A IL169335A0 (en) 2002-12-23 2005-06-22 PYRAZOLO[3,4,-b] PYRIDINE COMPOUNDS, AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS
CO05061771A CO5690642A2 (en) 2002-12-23 2005-06-23 PIRAZOLO COMPOUNDS [3,4-B] PIRIDINE, AND ITS USE AS PHOSPHODESTERASE INHIBITORS
IS7913A IS2795B (en) 2002-12-23 2005-06-23 Pyrazolo [3,4-b] pyridine compounds, and their use as phosphodiesterase inhibitors
MA28404A MA27615A1 (en) 2002-12-23 2005-07-20 PYRAZOLO [3,4-B] PYRIDINE COMPOUNDS AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS
NO20053600A NO332354B1 (en) 2002-12-23 2005-07-22 Pyrazolo [3,4-b] pyridine compounds, pharmaceutical compositions comprising such compounds and their use in the manufacture of medicaments for the treatment of disease
HK06104030.8A HK1084384A1 (en) 2002-12-23 2006-03-31 Pyrazolo [3,4-b]pyridine compounds, and their use as phosphodiesterase inhibitors
ZA200605901A ZA200605901B (en) 2002-12-23 2006-07-17 Pyrazolo [3,4-B] pyridine compounds, and their use as phosphodiesterase inhibitors
AU2010202035A AU2010202035B9 (en) 2002-12-23 2010-05-19 Pyrazolo[3,4-b]pyridine compounds, and their use as phosphodiesterase inhibitors
CY20101100688T CY1110676T1 (en) 2002-12-23 2010-07-21 PYRAZOLO [3,4-b] Pyridine compounds, and their use as phosphodiesterase inhibitors

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0307998A GB0307998D0 (en) 2003-04-07 2003-04-07 Compounds

Publications (1)

Publication Number Publication Date
GB0307998D0 true GB0307998D0 (en) 2003-05-14

Family

ID=9956336

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0307998A Ceased GB0307998D0 (en) 2002-12-23 2003-04-07 Compounds

Country Status (1)

Country Link
GB (1) GB0307998D0 (en)

Similar Documents

Publication Publication Date Title
GB0309781D0 (en) Compounds
GB0316915D0 (en) Compounds
GB0315950D0 (en) Compounds
GB0305559D0 (en) Compounds
GB0317268D0 (en) Compounds
GB0314476D0 (en) Compounds
GB0314479D0 (en) Compounds
GB0314478D0 (en) Compounds
EP1689403A4 (en) Heteroaryl-hydrazone compounds
GB0304665D0 (en) Compounds
GB0305553D0 (en) Compounds
GB0313915D0 (en) Compounds
GB0306329D0 (en) Compounds
GB0313914D0 (en) Compounds
EP1658301A4 (en) N-desmethyl-n-substituted-11-deoxyerythromycin compounds
EP1682514A4 (en) 11- o-methylgeldanamycin compounds
GB0302512D0 (en) Compounds
GB0304494D0 (en) Compounds
GB0317269D0 (en) Compounds
GB0307366D0 (en) Compounds
GB0305717D0 (en) Compounds
GB0310849D0 (en) Compounds
GB0307998D0 (en) Compounds
GB0310067D0 (en) Compounds
GB0310066D0 (en) Compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)